ClinicalTrials.Veeva

Menu

Immature Myeloid Cells in Respiratory Syncytial Virus Bronchioliltis

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Bronchiolitis

Treatments

Other: Respiratory secretions obtained

Study type

Observational

Funder types

Other

Identifiers

NCT01684527
0039-12-HYMC

Details and patient eligibility

About

The investigators hypothesize that Respiratory Syncytial Virus (RSV) infection may influence the population of lung immature myeloid cells and dendritic cells in a way that will impair their ability to invoke an effective immune response and lead to prolonged inflammation, angiogenesis and scarring. This may lead in turn to disturbed lung function.

Our aim is to determine the presence and phenotype of immature myeloid cells present in respiratory secretions of children with RSV bronchiolitis as compared to non-RSV bronchiolitis and healthy controls.

Enrollment

55 estimated patients

Sex

All

Ages

Under 2 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Bronchiolitis

Exclusion criteria

  • Chronic disease

Trial design

55 participants in 2 patient groups

Children Suffering From Bronchiolitis
Description:
Respiratory secretions obtained from children suffering from Bronchiolitis
Treatment:
Other: Respiratory secretions obtained
Healthy Children
Description:
Respiratory secretions obtained from children with no respiratory infection
Treatment:
Other: Respiratory secretions obtained

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems